Advanced in Usher Syndrome

Dr. Bart P. Leroy

Ophthalmology
34th & Civic Center Blvd, Children's Hospital Of Philadelphia, 
Philadelphia, PA 
Advanced in Usher Syndrome
34th & Civic Center Blvd, Children's Hospital Of Philadelphia, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bart Leroy is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Leroy is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Usher Syndrome.

Specialties
Ophthalmology
Licenses
Ophthalmology in PA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
Translational Stem Cell Research in Ophthalmology - Regenerating the Anterior Cornea Through Standardized Transplantation of Limbal Epithelial Stem Cells: a Phase II Multicenter Trial
Translational Stem Cell Research in Ophthalmology - Regenerating the Anterior Cornea Through Standardized Transplantation of Limbal Epithelial Stem Cells: a Phase II Multicenter Trial
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Biological
Study Drug: Limbal epithelial stem cell graft
Study Phase: Phase 2
An Open-Label, Extension Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-Label, Extension Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Enrollment Status: Terminated
Publish Date: October 15, 2024
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Evaluation of Light Sensitivity and Visual Acuity Changes as Consequence of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris
Evaluation of Light Sensitivity and Visual Acuity Changes as Consequence of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris
Enrollment Status: Terminated
Publish Date: April 27, 2022
Intervention Type: Device, Drug
Study Phase: Not Applicable
Double-masked, Randomized, Controlled, Multiple-dose Study to Evaluate Efficacy, Safety, Tolerability and Syst. Exposure of QR-110 in Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Double-masked, Randomized, Controlled, Multiple-dose Study to Evaluate Efficacy, Safety, Tolerability and Syst. Exposure of QR-110 in Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Enrollment Status: Active_not_recruiting
Publish Date: March 17, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

174 Total Publications

Quality of life in children and adolescents with visual impairment: key pillars of support explored through a qualitative analysis among different healthcare professionals in the Flemish healthcare landscape.
Quality of life in children and adolescents with visual impairment: key pillars of support explored through a qualitative analysis among different healthcare professionals in the Flemish healthcare landscape.
Journal: Disability and rehabilitation
Published: October 21, 2025
Similar Doctors
Distinguished in Usher Syndrome
Dr. Tomas S. Aleman
Ophthalmology
Distinguished in Usher Syndrome
Dr. Tomas S. Aleman
Ophthalmology

Scheie Eye Institute Perelman

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (0.2 miles away)
215-662-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tomas Aleman is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Aleman is rated as an Elite provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Leber Congenital Amaurosis, Choroideremia, Retinopathy Pigmentary Mental Retardation, and Cone-Rod Dystrophy. Dr. Aleman is currently accepting new patients.

Distinguished in Usher Syndrome
Dr. Alexander J. Brucker
Ophthalmology
Distinguished in Usher Syndrome
Dr. Alexander J. Brucker
Ophthalmology

Scheie Eye Institute Radnor

145 King Of Prussia Road, Floor 2, Suite 204 South, 
Radnor, PA 
 (10.6 miles away)
215-662-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alexander Brucker is an Ophthalmologist in Radnor, Pennsylvania. Dr. Brucker is rated as a Distinguished provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Retinal Artery Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy. Dr. Brucker is currently accepting new patients.

Distinguished in Usher Syndrome
Dr. Jijo J. Wang
Ophthalmology
Distinguished in Usher Syndrome
Dr. Jijo J. Wang
Ophthalmology

Ophthalmic Physicians Of Monmouth, PA

733 North Beers Street, Suite U4, 
Holmdel, NJ 
 (60.0 miles away)
732-739-0707
Experience:
10+ years
Languages Spoken:
English, Mandarin
See accepted insurances

Jijo Wang is an Ophthalmologist in Holmdel, New Jersey. Dr. Wang has been practicing medicine for over 10 years and is rated as a Distinguished provider by MediFind in the treatment of Usher Syndrome. Her top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Usher Syndrome, Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leroy's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile